Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion

INTRODUCTION: To investigate treatment outcomes after switching from ranibizumab to aflibercept intravitreal injections in patients with macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). METHODS: Eligible patients with refractory MO secondary to BRVO, post treatment with a minim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ophthalmol Ther
Autori principali: Konidaris, Vasileios E., Tsaousis, Konstantinos T., Anzidei, Rossella, de la Mata, Guillermo, Brent, Alexander J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258582/
https://ncbi.nlm.nih.gov/pubmed/30288685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-018-0149-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi